Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2014

May 9, 2014

30016_dirs_2014-05-09_cca75355-0395-4628-94ec-78aa7e8bb8ef.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2014-05-07

Reporting Person: MURRAY ROBERT J (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-05-07 Common Stock M 429 Acquired 26935 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-05-07 Restricted Stock Unit $ A 290 Acquired Common Stock (290) Direct
2014-05-07 Non-Qualified Stock Options (right to buy) $129.38 A 2987 Acquired 2024-05-06 Common Stock (2987) Direct
2014-05-07 Restricted Stock Units $ M 429 Disposed Common Stock (429) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 8248 Indirect
Common Stock 3000 Indirect

Footnotes

F1: Reflects change in form of ownership of 2,278 shares from indirect through Grantor Retained Annuity Trust formed on 12/20/2012 (2012 GRAT) to direct, following 2012 GRAT annuity payment to the reporting person on 03/05/2014.

F2: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest one year from the date of grant (05/07/2014).

F3: Grant of options to buy shares of common stock that vest one year from the date of grant (05/07/2014).

F4: Represents restricted stock units previously granted on 05/08/2013 that have vested. Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock.